0001610717-24-000160.txt : 20240313 0001610717-24-000160.hdr.sgml : 20240313 20240313163201 ACCESSION NUMBER: 0001610717-24-000160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horn Margaret A CENTRAL INDEX KEY: 0001294192 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 24746411 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 form4.xml X0508 4 2024-03-11 0001628171 Revolution Medicines, Inc. RVMD 0001294192 Horn Margaret A C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063 true Chief Operating Officer true Common Stock 2024-03-11 4 M 0 15735 4.09 A 158202 D Common Stock 2024-03-11 4 S 0 15735 34.0201 D 142467 D Common Stock 2024-03-12 4 M 0 7936 4.09 A 150403 D Common Stock 2024-03-12 4 S 0 7936 34.0657 D 142467 D Stock Option (Right to Buy) 4.09 2024-03-11 4 M 0 15735 0 D 2023-03-13 2029-03-12 Common Stock 15735 52567 D Stock Option (Right to Buy) 4.09 2024-03-12 4 M 0 7936 0 D 2023-03-13 2029-03-12 Common Stock 7936 44631 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 29, 2023. Includes 100,013 restricted stock units. This transaction was executed in multiple trades in prices ranging from $34.00 to $34.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. This transaction was executed in multiple trades in prices ranging from $34.00 to $34.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Jack Anders, as Attorney-in-fact for Margaret Horn 2024-03-13